Boehringer lngelheim Therapeutics GmbH

LEI: 391200OM7ZQLVZV6LJ42
Germany
Last updated: Jan 22, 2026
ACTIVEISSUED

Entity Information

Legal Entity Identifier (LEI)
391200OM7ZQLVZV6LJ42
Registration ID
HRB 641666(ID: RA000355)
Legal Form
2HBR
Jurisdiction
Germany
Legal address country
Germany

Entity Names

Legal Name

Boehringer lngelheim Therapeutics GmbH(Language: de)

Addresses

Legal Address

Untere Wiesen 22
Ochsenhausen, DE-BW, 88416, Germany

Loading map...

Headquarters Address

Untere Wiesen 22
Ochsenhausen, DE-BW, 88416, Germany

Loading map...

Additional Information

Entity Status

Current Status

ACTIVE

Need to maintain compliance?

LEIs must be renewed annually to keep your entity's information up to date

Renew this LEI

Reference Guide

LEI status meaning

This LEI is issued, which usually means the registration is active and suitable for current reference and compliance checks.

Renewal date

The next renewal date is March 3, 2027. This is the key deadline for keeping the LEI record current.

Jurisdiction

Boehringer lngelheim Therapeutics GmbH is registered under jurisdiction DE. Match that jurisdiction with the legal address and local registration number before relying on the LEI.

Parent and ultimate parent

Direct parent is linked to LEI 529900P5FAANZASUYL28, with relationship status active. Ultimate parent is linked to LEI 529900P5FAANZASUYL28, with relationship status active.

How to verify this entity

  1. Match the legal name "Boehringer lngelheim Therapeutics GmbH" to the entity you expect.
  2. Check local registration number HRB 641666 against authority RA000355.
  3. Confirm the validation source RA000355 and reference HRB 641666.

LEI Verified Badge

Display your verified LEI status on your website with our free badge widget

Get Your Badge Code

Click "Show Code" to view the HTML code for your LEI Verified badge

Entity & LEI Status Summary

This Legal Entity Identifier (LEI) record pertains to Boehringer lngelheim Therapeutics GmbH, identified by the LEI 391200OM7ZQLVZV6LJ42. The entity is formally registered under the jurisdiction of Germany (via RA000355, registered as HRB 641666) and lists its legal address country as Germany. It operates under the legal structure defined as "2HBR", classified under the category "GENERAL".

The current operational status of the entity is reported as "ACTIVE". The LEI registration itself is currently "ISSUED", managed by the Local Operating Unit (LOU) 5299000J2N45DDNE4Y28. Key dates associated with this registration include its initial establishment on Jan 10, 2018, its most recent update on Jan 22, 2026, and a scheduled renewal date of Mar 3, 2027.

Maintaining an active and up-to-date LEI is crucial for Boehringer lngelheim Therapeutics GmbH to ensure continuous participation in global financial markets and regulatory reporting. The corroboration level for this record is "FULLY_CORROBORATED", indicating the extent to which the information has been verified against official registers. The primary validation of this information was performed by RA000355 (as HRB 641666).

Registration Details

Timeline

  • Initial Registration
    Jan 10, 2018
  • Last Updated
    Jan 22, 2026
  • Next Renewal
    Mar 3, 2027

Validation

Primary Validation

Authority ID
RA000355
Registration Number
HRB 641666

Status Information

Registration Status
ISSUED
Corroboration Level
FULLY_CORROBORATED

Managing Authority

Local Operating Unit (LOU)
5299000J2N45DDNE4Y28

Corporate Structure

Direct Parent

Parent Entity

LEI: 529900P5FAANZASUYL28

Relationship: IS DIRECTLY CONSOLIDATED BYStatus: ACTIVE
View Details

Ultimate Parent

Ultimate Parent Entity

LEI: 529900P5FAANZASUYL28

Relationship: IS ULTIMATELY CONSOLIDATED BYStatus: ACTIVE
View Details

Corporate Structure Visualization

Direct & Ultimate Parent
LEI: 529900P5FAANZASUYL28
Boehringer Ingelheim Animal Health Japan Holding GmbH
LEI: 529900U5OPY9L9FPUT06
AMAL THERAPEUTICS SA
LEI: 52990091QOK2WBQB9Q20
T3 Pharmaceuticals AG
LEI: 5299007PVTWSJ7OO3F95
Boehringer Ingelheim Venture Fund Asia Limited
LEI: 5299000DCDFD8KQS3R46
Boehringer Ingelheim Promeco S.A. de C.V.
LEI: 529900HD97DI6LXV5A66
Boehringer Ingelheim Europe GmbH
LEI: 529900PUK2W10R64SZ68
Boehringer Ingelheim Animal Health Participations GmbH
LEI: 529900SEAMD5W7ON9N16
AGC PHARMA CHEMICALS EUROPE S.L.
LEI: 529900C4WABB6Z4IH613
Boehringer Ingelheim India Private Limited
LEI: 5299007CWFCKHPNNVB87
Boehringer Ingelheim Venture Fund GmbH
LEI: 529900NUBLYH7ZS6N833
Boehringer Ingelheim R&D Beteiligungs GmbH
LEI: 529900UQ5DB7A8NI6P20
Boehringer Ingelheim Animal Health International GmbH
LEI: 529900MQK0OTRJOPUS81
BOEHRINGER INGELHEIM N Z LIMITED
LEI: 5299001NIRDJO24MWD45
Boehringer Ingelheim Pty Ltd
LEI: 529900UG193CFEDVWX57
Siblings
Boehringer lngelheim Therapeutics GmbH
LEI: 391200OM7ZQLVZV6LJ42
Legend:
Current Entity
Parent Entity
Child Entity
Sibling Entity
Owned by / Child of
Owns / Parent of
Exception Reported

Relationship overview showing parent, sibling, and child entities linked to this LEI.

Child Entities

No child entities found